'24e EBIT (core) largely unchanged following a weak Q1. Temporary headwinds from poor biology and weak demand. Weaker outlook, but valuation support; BUY, TP NOK 27 (28).
Salmon prices higher on another blow to '24e supply, but farmers struggling to reap the benefits due to weak biology. Valuation not demanding, but more mixed triggers short term.
Q1'24e EBIT of USD -1m (FactSet cons. at USD 11m). '24e EBIT slashed on weaker prices and biology. '25e P/E of 7x screens well, but risk has increased.